Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 3163 for “"Prostate--Cancer"”.
-
Microrna Regulation of Prostate Cancer Stem/Progenitor Cells and Prostate Cancer Development
… of cells with stem cell properties, called cancer stem cells (CSCs), which are believed to be responsible for tumor establishment, metastasis, and resistance to clinical therapy. It’s crucial to understand the regulatory mechanisms unique to CSCs, so that we may design CSC-specific …
-
STAT3 in Prostate Cancer
Prostate cancer is the second most common diagnosed cancer among men. Currently there are no reliablebiomarkers to distinguish between indolent and aggressive disease. When men progress to advanced stages of the disease treatment options are limited and resistance to treatments available today is a …
-
MiRNAs and prostate cancer
… In this thesis, the deregulation of miRNAs in prostate cancer was investigated. miRNA microarray profiling was performed in fresh frozen prostate cancer and matched normal adjacent tissues. Differentially expressed miRNAs were subsequently validated by real-time quantitative PCR (RT-qPCR). …
-
Understanding Prostate Cancer Pathogenesis
Prostate cancer is the most prevalent type of cancer in men. However, there is no cure for relapsed androgen withdrawal-refractory prostate cancer which is fatal due to metastasis. Many studies have demonstrated the existence of cancer cells with stem cell properties (aka cancer propagating cells …
-
Fatigue and prostate cancer
… Fatigue is a common and debilitating problem for cancer patients. It is associated with cancer or its treatment. Evidence suggests fatigue may be prolonged after treatment for some cancers and could be associated with a host systemic inflammatory response. Prostate cancer is the commonest male …
-
Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis
… average, 65 Canadian men will be diagnosed with prostate cancer (PC) every day, making it the most common male cancer in Canada. Despite the prevalence, the etiology of PC is unknown. Evidence nonetheless supports the role of prostate cancer stem cells (PCSCs) in PC initiation and metastasis. In …
-
EXAMINATION OF PROSTATE CANCER ASSOCIATED FACTORS FOR THEIR CONTRIBUTION TOWARDS THE DEVELOPMENT OF PROSTATE CANCER AND PROGRESSION INTO CASTRATION RESISTANT PROSTATE CANCER
Although early detection and treatment of prostate cancer (PC) shows clinical benefit, advanced PCs that progress despite androgen deprivation therapy almost invariably result in castration resistance. This progression is lethal as castration-resistant prostate cancer (CRPC) are intimately …
-
Prostate Cancer Chemoprevention With Genistein And Resveratrol In Models Of Spontaneously Developing Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. The goal of this research was to investigate the potential of three nutriceutical polyphenols, genistein, resveratrol, and epigallocatechin-3-gallate (EGCG), to suppress prostate cancer. Cancer …
-
MICRONUTRIENTS AND PROSTATE CANCER RISK
… the associations between micronutrients and prostate cancer risk. In the Singapore Prostate Cancer Study, a hospital-based case-control study, higher serum concentrations of retinol, lutein, α-carotene, β-carotene, ubiquinone, α-tocopherol, δ-tocotrienol, γ-tocotrienol, α-tocotrienol were …
-
Gene expression in prostate cancer
Development and maintenance of the prostate is dependent on androgens and the androgen receptor. The androgen pathway continues to be important in prostate cancer. Here, we evaluated the transcriptome of prostate cancer cells in response to androgen using Long Serial Analysis of Gene Expression …
-
Nanotherapies for Treating Prostate Cancer
Current prostate cancer treatment remains ineffective primarily due to ineffectual therapeutic strategies and numerous tumor-associated physiological barriers which hinder efficacy of anticancer agents. Therefore, the focus of this study was to investigate a new combination therapy approach for …
-
Transcriptomic subtyping of prostate cancer
Prostate cancer is the second most commonly diagnosed cancer in men and the fifth leading cause of cancer death in men worldwide. While survival rates in prostate cancer are high, there is a risk of metastatic recurrence following primary treatment. Currently, there is no molecular subtyping system …
-
Prostate cancer, the screening conundrum
… overview of the literature pertaining to prostate cancer screening and early detection rationale, the significance of prostate cancer and the impact on health care, particularly treatment modalities. Secondary data bases published by the Canadian Cancer Society and data from published …
-
Investigating ARID1A in prostate cancer
Prostate cancer (PC) is the most common cancer in men in the developed world, and the second leading cause of cancer death in the U.K. Most of these deaths are caused by the advanced and metastatic forms of this disease which have no curative options. Understanding and targeting metastatic prostate …
-
Prostate cancer and bone health
Introduction Both prostate cancer (PC) and its treatment have important effects on bone and body composition. Three distinct mechanisms affect bone; androgen deprivation therapy (ADT); use of chemotherapy and systemic glucocorticoids (GC), and bone metastases (BM). Work undertaken in this thesis …
-
PSMA theranostics in prostate cancer
Contains fulltext : 252883.pdf (Publisher’s version ) (Open Access)
-
Prostate cancer multifocality and heterogeneity
Contains fulltext : 146671.pdf (Publisher’s version ) (Open Access)
-
Nonsteroidal antiandrogens in prostate cancer
Contains fulltext : 145644.pdf (Publisher’s version ) (Open Access)
-
(Pre)targeting of prostate cancer
Contains fulltext : 157647.pdf (Publisher’s version ) (Open Access)
Page 1 of 159